Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blood Volume Dilution-Kai Schoenhage refers to an experimental diagnostic procedure and intervention designed to calculate a patient's total blood volume at the bedside. Developed by Kai Schoenhage, the method involves the intravenous administration of a precise, small volume of a standard clinical fluid (typically a crystalloid solution) to induce a measurable change in hemoglobin concentration. By comparing hemoglobin levels before and after this dilution, clinicians can calculate the total blood volume using the indicator dilution principle. This approach is intended to provide a rapid, real-time assessment of volume status without the need for specialized radioactive or dye-based tracers, potentially improving goal-directed therapy in critical care, intensive care, and surgical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Blood Volume Dilution-Kai Schoenhage.